SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+5.42%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$397M
AUM Growth
+$397M
(-7.2%)
Cap. Flow
-$6.43B
Cap. Flow
% of AUM
-1,620.74%
Top 10 Holdings %
Top 10 Hldgs %
50.42%
Holding
141
New
34
Increased
17
Reduced
25
Closed
47
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$20.1M |
| 2 |
SHPG
Shire pic
SHPG
|
$14.1M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$7.47M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$6.77M |
| 5 |
Verint Systems
VRNT
|
$6.6M |
Top Sells
| 1 |
SMMF
Summit Financial Group, Inc.
SMMF
|
$6.4B |
| 2 |
Sanofi
SNY
|
$21.2M |
| 3 |
GSK
GSK
|
$18.7M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
$15.2M |
| 5 |
Eli Lilly
LLY
|
$12.4M |
Sector Composition
| 1 | Healthcare | 75.29% |
| 2 | Technology | 4.17% |
| 3 | Consumer Discretionary | 3.58% |
| 4 | Industrials | 2.99% |
| 5 | Communication Services | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCYC
26
DELISTED
PHARMACYCLICS INC
PCYC
| $4.49M | 1.11% |
+50,000
| New | +$4.49M |
|
|
TW
27
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $4.35M | 1.07% |
+41,740
| New | +$4.35M |
|
|
CLVS
28
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.35M | 1.07% |
105,000
+65,000
| +163% | +$2.69M |
|
29
Gilead Sciences
GILD
$140B
| $4.15M | 1.02% |
50,000
-44,000
| -47% | -$3.65M |
|
30
Incyte
INCY
$17B
| $4.12M | 1.02% |
73,000
-10,000
| -12% | -$564K |
|
31
PTC Therapeutics
PTCT
$4.41B
| $3.92M | 0.97% |
+150,000
| New | +$3.92M |
|
|
EPZM
32
DELISTED
Epizyme, Inc
EPZM
| $3.52M | 0.87% |
+113,188
| New | +$3.52M |
|
33
Colgate-Palmolive
CL
$67.7B
| $3.26M | 0.8% |
47,799
-15,000
| -24% | -$1.02M |
|
34
AutoNation
AN
$8.31B
| $3.14M | 0.77% |
+52,600
| New | +$3.14M |
|
|
BRCM
35
DELISTED
BROADCOM CORP CL-A
BRCM
| $2.94M | 0.72% |
79,120
-33,380
| -30% | -$1.24M |
|
36
Caesarstone
CSTE
$47.3M
| $2.93M | 0.72% |
59,600
+51,770
| +661% | +$2.54M |
|
|
AERI
37
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.73M | 0.67% |
110,000
-2,500
| -2% | -$61.9K |
|
|
TTPH
38
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $2.67M | 0.66% |
+198,000
| New | +$2.67M |
|
|
AMPE
39
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $2.61M | 0.64% |
312,000
+87,000
| +39% | +$726K |
|
|
RCPT
40
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $2.56M | 0.63% |
+60,000
| New | +$2.56M |
|
41
MacroGenics
MGNX
$121M
| $2.41M | 0.59% |
111,000
+70,000
| +171% | +$1.52M |
|
|
EIGR
42
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.4M | 0.59% |
+150,000
| New | +$2.4M |
|
|
CASC
43
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $2.39M | 0.59% |
738,336
| – | – |
|
44
Booking.com
BKNG
$181B
| $2.32M | 0.57% |
1,932
-310
| -14% | -$373K |
|
45
Vanda Pharmaceuticals
VNDA
$279M
| $2.27M | 0.56% |
140,000
+75,000
| +115% | +$1.21M |
|
46
Actinium Pharmaceuticals
ATNM
$53.3M
| $2.17M | 0.53% |
+300,000
| New | +$2.17M |
|
47
Akebia Therapeutics
AKBA
$827M
| $2.02M | 0.5% |
+72,500
| New | +$2.02M |
|
|
IMMU
48
DELISTED
Immunomedics Inc
IMMU
| $2.01M | 0.49% |
550,000
+250,000
| +83% | +$913K |
|
|
TRVN
49
DELISTED
Trevena, Inc.
TRVN
| $1.93M | 0.47% |
341,000
+91,000
| +36% | +$515K |
|
|
AMBI
50
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $1.92M | 0.47% |
277,568
+129,100
| +87% | +$892K |
|